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lymphadenopathy with histological feature of 
HNL. The development of HNL did not affect 
the course of her MCTD. The aim of our report 
was to highlight the peculiarity of presentation 
of this condition as bilateral hilar lymphaden- 
opathy, which would be of immense interest to 
pulmonologists and pulmonary pathologists. 
Unlike their patient, ours had none of the 
American Rheumatism Association clinical cri- 
teria for the diagnosis of SLE (2), hence our 
failure to pursue laboratory criteria. We have 
followed this patient now for nearly 4 years. He 
remains well and asymptomatic. 
The variable presentation and progression and 
the association with various physical, chemical, 
autoimmune and infective conditions indicates 
that this condition is a consequence of one or 
more (variable) stimuli. Until a unitary expla- 
nation is identified, it is best to treat each patient 
on merit. 
A. A. ABBA 
Department of Medicine 
King Saudi University 
Riyadh, Saudi Arabia 
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Dear Editor 
Chylothorax in liver cirrhosis 
We have read with great interest the article by 
Valdks et al. (1) in which two cases of chylo- 
thorax caused by liver cirrhosis were reported. 
The authors emphasize the rarity of chylothorax 
secondary to hepatic cirrhosis, which makes up 
approximately 1% of all chylothorax patients. 
We wish to report another patient with right 
cylothorax due to liver cirrhosis. 
A 76-year-old woman was hospitalized in June 
1988 because of dyspnoea of several days dur- 
ation. Postnecrotic hepatic cirrhosis had been 
diagnosed 19 years before. In that time, portal 
hypertension was present. A splenorenal shunt 
and splenectomy were performed. Six months 
before admission, ascites developed. Paracen- 
tesis resulted in the removal of 3500 ml of milky 
liquid. Biochemical investigation of the perito- 
neal fluid was as follows: total protein 3.2 g 
dl- ‘, lactate dehydrogenase (LDH) 87 IU 1 - I, 
glucose 115 mg dl-l, cholesterol 34 mg dl - ‘, 
triglycerides 193 mg dl - ‘, amylase 173 U 1 - ‘, 
lysozyme 21.2 mg dl- ‘, a,-antitrypsin 125 mg 
dl - I, carcino-embryonic antigen (CEA) 0.33 ng 
ml-‘, pH 7.40, PCO, 43.5 mmHg, PO, 
73 mmHg, [HC03-] 27.5 mEq l- ‘, leucocytes 
1100 mmp3. Gram stain, acid-fast stain, culture 
and cytologic findings for malignancy were nega- 
tive. On admission, clinical examination showed 
chronic hepatopathic stigmata, hepatomegaly, 
ascites and a right-sided pleural effusion con- 
firmed by chest radiograph. Blood pressure was 
120/70 mmHg, and heart rate was 84 beats 
min- ‘. Blood analysis results were as follows: 
haemoglobin 12.8 g dl - ‘, haematocrit 38%, 
leucocytes 7500 mm - 3, differential leucocyte 
counts normal, platelet count 256 000 mm - 3, 
prothrombin activity 53%, partial thromboplas- 
tin time 30.5 s, total protein 7.36 g dl- ‘, total 
bilirubin O-8 1 mg dl - ‘, triglycerides 34 mg dl ~ ‘, 
cholesterol 123 mg dl - ‘, creatinine 2.24 mg 
dl - ‘, blood ammonia 134 mg dl - ‘, immuno- 
globulin G 3430 mg dl- ‘, other biochemical 
parameters normal. Abdominal ultrasonography 
showed hepatomegaly without focal lesions and 
ascites. Thirteen thoracenteses, performed in a 
period of 3 months, resulted in the removal of 
29 500 ml of milky liquid. Characteristics of the 
pleural fluid were as follows: protein 2.3 g dl - ‘, 
pleural fluid: serum protein ratio 0.3, LDH 171 
IU l- ‘, pleural fluid: serum LDH ratio 0.4, 
glucose 90 mg dl - ‘, cholesterol 46 mg dl - ‘, 
triglycerides 121 mg dl - ‘, pleural fluid: serum 
triglycerides ratio 2.2, amylase 195 U 1~ ‘, 
lysozyme 22.2 mg dl - ‘, a,-antitrypsin 118 mg 
dl-l, CEA 1.3 ng ml ~ ‘, pH 7.48, PCO, 
45 mmHg, PO, 48.3 mmHg, [HC03-] 29.8 mEq 
1 - ‘, leucocytes 1200 mm - 3 of which 60% lym- 
phocytes, chylomicrons present. Gram stain, 
acid-fast stain, culture and cytologic findings for 
malignancy were negative. Total parenteral 
nutrition was started without reduction of 
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pleural effusion production. Severe malnutrition 
developed. The patient died 3 months after 
admission. At autopsy, there were no turnours, 
lesions of the thoracic duct or other causes of 
chylothorax. 
We prospectively studied aetiology of pleural 
effusions in 361 patients hospitalized in our 
Internal Medicine Department in a period 
between 1 January 1985 and 31 December 1995, 
following a pre-defined protocol. Aetiologic 
diagnosis was performed in 305 patients (84.5%). 
Only two patients (0.6%) had chylothorax, one 
patient had tuberous sclerosis (2) and the present 
patient had liver cirrhosis. Our case confirms 
that reported by Valdks et al. (1); chylothorax is 
an uncommon condition and hepatic cirrhosis is 
an exceptional cause which constitutes less than 
1% of cases. Pathogenesis of chylothorax 
involves direct passage of ascitic fluid into the 
pleural space through minute defects in the 
diaphragm, in the same way as pleural tran- 
sudates secondary to cirrhotic ascites. In our 
patient, autopsy failed to detect any defect 
located on the diaphragm. The management of 
chylothorax of cirrhotic origin is very important, 
since patients with chylothorax develop mal- 
nourishment and immunocompromise due to 
removal of large amounts of chyle with repeated 
thoracentesis. Recently, videothoracoscopy 
associated with talc pleurodesis has been pro- 
posed for the treatment of pleural effusion of 
cirrhotic origin (3). This method should also 
be considered in patients with chylothorax, to 
prevent the complications of malnutrition 
and infection when other modes of therapy are 
failing. 
V. FORESTI, A. VILLA AND N. SCOLARI 
III Medical Department 
Fatebenefratelli Hospital 
Milan, Italy 
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